comparemela.com

Latest Breaking News On - James vane tempest - Page 14 : comparemela.com

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from Jefferies

James Vane-Tempest from Jefferies retains his negative opinion on the stock with a Sell rating. The target price continues to be set at EUR 21. | April 19, 2023

SYNLAB : Jefferies gives a Neutral rating

In his latest research note, analyst James Vane-Tempest confirms his recommendation. The broker Jefferies is keeping its Neutral rating. The target price is still set at EUR 8.20. | March 13, 2023

Indivior PLC target price hiked after company raises forecast for new opioid addiction treatment

Indivior PLC (LSE:INDV) shares have been given a price target of 2,655p by Jefferies, implying over 40% upside, after the company raised sales guidance for.

Straumann Holding AG (SAUHF) Q3 2022 Earnings Call Transcript

Straumann Holding AG (OTCPK:SAUHF) Q3 2022 Results Conference Call November 02, 2022 5:30 AM ET Company Participants Guillaume Daniellot - CEO Peter Hackel - CFO Conference Call.

FRESENIUS SE : Jefferies reaffirms its Neutral rating

In a research note, Jefferies analyst James Vane-Tempest has maintained his recommendation on the stock with a Neutral rating. The target price remains unchanged at EUR 24. | October 31, 2022

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.